|
US2007037754A1
|
|
Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
|
|
AU2003200506B2
|
|
Method of solubilizing, purifying and refolding protein and compositions comprising proteins and solubilizing agents
|
|
BR0212495A
|
|
Method for the preparation of crystalline tetrahydrobenzothiepines
|
|
AU8081001A
|
|
Novel 1,4-benzothiazepine and 1,5-benzothiazepine compounds as inhibitors of apical sodium co-dependent bile acid transport and taurocholate uptake
|
|
ZA200105057B
|
|
Combinations of cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular indications.
|
|
EP1165136A1
|
|
Combination therapy of angiotensin converting enzyme inhibitor and epoxy-steroidal aldosterone antagonist for treatment of cardiovascular disease
|
|
HU0104655A2
|
|
Combinations for cardiovascular indications
|
|
EP1293211A1
|
|
Combinations of ileal bile acid transport inhibitors and bile acid sequestering agents for cardiovascular indications
|
|
EP1340508A1
|
|
Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acid derivatives for cardiovascular indications
|
|
IL143946D0
|
|
Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein for cardiovascular indications
|
|
EP1336413A1
|
|
Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular indications
|
|
IL143943D0
|
|
Combinations of ileal bile acid transport inhibitors and bile acid sequestering agents for cardiovascular indications
|
|
EP1714676A2
|
|
Use of N-substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds for treating hepatitis virus infections
|
|
IL158857D0
|
|
Processes for preparation of steroids and intermediates useful therein
|
|
EP0973791A2
|
|
Process for the preparation of an epoxy compound
|
